Literature DB >> 11765764

Owning genetic information and gene enhancement techniques: why privacy and property rights may undermine social control of the human genome.

A D Moore1.   

Abstract

In this article I argue that the proper subjects of intangible property claims include medical records, genetic profiles, and gene enhancement techniques. Coupled with a right to privacy these intangible property rights allow individuals a zone of control that will, in most cases, justifiably exclude governmental or societal invasions into private domains. I argue that the threshold for overriding privacy rights and intangible property rights is higher, in relation to genetic enhancement techniques and sensitive personal information, than is commonly suggested. Once the bar is raised, so-to-speak, the burden of overriding it is formidable. Thus many policy decisions that have been recently proposed or enacted--citywide audio and video surveillance, law enforcement DNA sweeps, genetic profiling, national bans on genetic testing and enhancement of humans, to name a few--will have to be backed by very strong arguments.

Entities:  

Keywords:  Analytical Approach; Biomedical and Behavioral Research; Genetics and Reproduction

Mesh:

Year:  2000        PMID: 11765764     DOI: 10.1111/1467-8519.00184

Source DB:  PubMed          Journal:  Bioethics        ISSN: 0269-9702            Impact factor:   1.898


  3 in total

1.  An economic viewpoint on alternative strategies for identifying persons with hereditary nonpolyposis colorectal cancer.

Authors:  Scott D Ramsey; Wylie Burke; Lauren Clarke
Journal:  Genet Med       Date:  2003 Sep-Oct       Impact factor: 8.822

2.  23andMe: a new two-sided data-banking market model.

Authors:  Henri-Corto Stoeklé; Marie-France Mamzer-Bruneel; Guillaume Vogt; Christian Hervé
Journal:  BMC Med Ethics       Date:  2016-03-31       Impact factor: 2.652

3.  Philosophical Perspectives on Doping Sanctions and Young Athletes.

Authors:  Sarah Teetzel
Journal:  Front Sports Act Living       Date:  2022-03-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.